Enforcement Report - Week of June 26, 2024
Enforcement Report - Week of May 15, 2024
Breckenridge Pharma`s Generic Rivaroxaban Receives Approval in the U.S.
Natco Pharma Limited vide its disclosure dated 8th September 2023 has informed that Celgene Corporation, Bristol Myers Squibb Company, Breckenridge Pharmaceutical and Natco Pharma Limited have been named defendants in an antitrust lawsuit in the US by Louisiana Health Service & Indemnity Company D/B/A Blue Cross and Blue Shield of Louisiana and HMO Louisiana, regarding Pomalidomide (POMALYST) capsules.
BRECKENRIDGE, Colo., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Breckenridge Distillery, the ‘World’s Highest Distillery,’ and Breckenridge Brewery return this season for the second ever Buddy Pass, a unique barrel-exchange program to create a limited-edition Imperial Stout Cask Finish Whiskey and a Whiskey Barrel-Aged Imperial Oatmeal Stout Beer. After selling out last year’s inaugural limited release in Colorado, Buddy Pass has expanded nationwide, entering 10 new markets and will hit retailers starting Oct. 24.
Breckenridge's Generic Bendamustine Hydrochloride Receives Approval in the U.S.
Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted approval of its Abbreviated New Drug...
Natco Pharma on Monday said its partner Breckenridge Pharmaceutical Inc has received approval from the US health regulator for generic Cabazitaxel intravenous powder used in the treatment of prostate cancer.
Breckenridge's Generic Cabazitaxel Receives Approval in US